 phase trial recombin human beta combin myelosuppress dose patient gastrointestin cancer dose recombin human beta beta myelosuppress dose patient gastrointestin cancer transient neutropenia monocytopenia lymphocytopenia mean dose-depend neutrophil leukocytosi day beta administr platelet count median day rang beta administr transient hypoglycemia rebound hyperglycemia elev serum cortisol c-reactiv protein side effect fever rigor headach major patient hypotens patient dose level micrograms/kg day neutropenia plu beta alon differ statist signific data beta stimulatori effect human hematopoiesi